-
1
-
-
0027353689
-
Neurobehavioral teratology of isotretinoin
-
Adams J, Lammer E. 1993. Neurobehavioral teratology of isotretinoin. Reprod Toxicol 7:175-177.
-
(1993)
Reprod Toxicol
, vol.7
, pp. 175-177
-
-
Adams, J.1
Lammer, E.2
-
2
-
-
34347238272
-
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects
-
DOI 10.1056/NEJMoa066584
-
Alwan S, Reefhuis J, Rasmussen S, et al. 2007. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356(26):2684-2692. (Pubitemid 47001036)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.26
, pp. 2684-2692
-
-
Alwan, S.1
Reefhuis, J.2
Rasmussen, S.A.3
Olney, R.S.4
Friedman, J.M.5
-
3
-
-
0032976445
-
Thalidomide and the Titanic: Reconstructing the technology tragedies of the twentieth century
-
Annas G, Elias S. 1999. Thalidomide and the Titanic: reconstructing the technology tragedies of the twentieth century. Am J Public Health 89(1):98-101. (Pubitemid 29281980)
-
(1999)
American Journal of Public Health
, vol.89
, Issue.1
, pp. 98-101
-
-
Annas, G.J.1
Elias, S.2
-
4
-
-
33847215461
-
First trimester exposure to paroxetine and risk of cardiac malformations in infants: The importance of dosage
-
DOI 10.1002/bdrb.20099
-
Berard A, Ramos E, Rey E, et al. 2007. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol 80(1):18-27. (Pubitemid 46303265)
-
(2007)
Birth Defects Research Part B - Developmental and Reproductive Toxicology
, vol.80
, Issue.1
, pp. 18-27
-
-
Berard, A.1
Ramos, E.2
Rey, E.3
Blais, L.4
St-Andre, M.5
Oraichi, D.6
-
6
-
-
62749199801
-
Why animal studies are often poor predictors of human reactions to exposure
-
Bracken M. 2009. Why animal studies are often poor predictors of human reactions to exposure. J R Soc Med 102(3):120-122.
-
(2009)
J R Soc Med
, vol.102
, Issue.3
, pp. 120-122
-
-
Bracken, M.1
-
7
-
-
1842587382
-
Utilization of Animal Studies to Determine the Effects and Human Risks of Environmental Toxicants (Drugs, Chemicals, and Physical Agents)
-
Brent R. 2004. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents). Pediatrics 113(4 Suppl):984-995. (Pubitemid 38437351)
-
(2004)
Pediatrics
, vol.113
, Issue.4 II
, pp. 984-995
-
-
Brent, R.L.1
-
8
-
-
59849102866
-
Determination of human teratogenicity by the astute clinician method: Review of illustrative agents and a proposal of guidelines
-
Carey J, Martinez L, Balken E, et al. 2009. Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines. Birth Defects Res A Clin Mol Teratol 85(1):63-68.
-
(2009)
Birth Defects Res a Clin Mol Teratol
, vol.85
, Issue.1
, pp. 63-68
-
-
Carey, J.1
Martinez, L.2
Balken, E.3
-
9
-
-
0030299068
-
Thalidomid, a current teratogen in South America
-
DOI 10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#
-
Castilla E, Ashton-Prolla P, Barreda-Mejia E, et al. 1996. Thalidomide, a current teratogen in South America. Teratology 54:273-277. (Pubitemid 27186921)
-
(1996)
Teratology
, vol.54
, Issue.6
, pp. 273-277
-
-
Castilla, E.E.1
Ashton-Prolla, P.2
Barreda-Mejia, E.3
Brunoni, D.4
Cavalcanti, D.P.5
Correa-Neto, J.6
Delgadillo, J.L.7
Dutra, M.G.8
Felix, T.9
Giraldo, A.10
Juarez, N.11
Lopez-Camelo, J.S.12
Nazer, J.13
Orioli, I.M.14
Paz, J.E.15
Pessoto, M.A.16
Pina-Neto, J.M.17
Quadrelli, R.18
Rittler, M.19
Rueda, S.20
Saltos, M.21
Sanchez, O.22
Schuler, L.23
more..
-
10
-
-
35648959287
-
Paroxetine in the first trimester and the prevalence of congenital malformations
-
DOI 10.1002/pds.1463
-
Cole J, Ephross S, Cosmatos I, Walker A. 2007. Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 16(10):1075-1085. (Pubitemid 350020060)
-
(2007)
Pharmacoepidemiology and Drug Safety
, vol.16
, Issue.10
, pp. 1075-1085
-
-
Cole, J.A.1
Ephross, S.A.2
Cosmatos, I.S.3
Walker, A.M.4
-
12
-
-
0026522941
-
Epidemiology of isotretinoin exposure during pregnancy
-
Dai W, LaBraico J, Stern R. 1992. Epidemiology of isotretinoin exposure during pregnancy. J Am Acad Dermatol 26(4):599-606.
-
(1992)
J Am Acad Dermatol
, vol.26
, Issue.4
, pp. 599-606
-
-
Dai, W.1
Labraico, J.2
Stern, R.3
-
13
-
-
55149097035
-
Paroxetine and fluoxetine in pregnancy: A prospective, multicentre, controlled, observational study
-
Diav-Citrin O, Shechtman S, Weinbaum D, et al. 2008. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 66(5):695-705.
-
(2008)
Br J Clin Pharmacol
, vol.66
, Issue.5
, pp. 695-705
-
-
Diav-Citrin, O.1
Shechtman, S.2
Weinbaum, D.3
-
14
-
-
44949160055
-
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy
-
DOI 10.1176/appi.ajp.2007.07060879
-
Einarson A, Pistelli A, DeSantis M, et al. 2008. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 165(6):749-752. (Pubitemid 351810544)
-
(2008)
American Journal of Psychiatry
, vol.165
, Issue.6
, pp. 749-752
-
-
Einarson, A.1
Pistelli, A.2
Desantis, M.3
Malm, H.4
Paulus, W.D.5
Panchaud, A.6
Kennedy, D.7
Einarson, T.R.8
Koren, G.9
-
15
-
-
55249117952
-
A review of modern multiple hypothesis testing, with particular attention to the false discovery proportion
-
Farcomeni A. 2008. A review of modern multiple hypothesis testing, with particular attention to the false discovery proportion. Stat Methods Med Res 17(4):347-388.
-
(2008)
Stat Methods Med Res
, vol.17
, Issue.4
, pp. 347-388
-
-
Farcomeni, A.1
-
16
-
-
68949113891
-
-
Healthcare Professional Sheet. Available at Accessed June 9, 2009
-
FDA Alert. 2008. Mycophenolate mofetil (marketed as CellCept) and mycophenolic acid (marketed as Myfortic). Healthcare Professional Sheet. Available at http://www.fda.gov/Drugs/DrugSafety/Postmarket/ DrugSafetyInformation for PatientsandProviders/ucm124776. htm. Accessed June 9, 2009.
-
(2008)
Mycophenolate Mofetil (Marketed As CellCept) and Mycophenolic Acid (Marketed As Myfortic)
-
-
-
18
-
-
33644528751
-
Antidepressant drugs during pregnancy and infant congenital heart defect [1]
-
DOI 10.1016/j.reprotox.2005.11.006, PII S0890623805002364
-
Kallen B, Otterblad Olausson P. 2006. Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 21(3):221-222. (Pubitemid 43294548)
-
(2006)
Reproductive Toxicology
, vol.21
, Issue.3
, pp. 221-222
-
-
Kallen, B.1
Otterblad Olausson, P.2
-
19
-
-
34250842467
-
Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations
-
DOI 10.1002/bdra.20327
-
Kallen B, Otterblad Olausson P. 2007. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 79(4):301-308. (Pubitemid 46980405)
-
(2007)
Birth Defects Research Part a - Clinical and Molecular Teratology
, vol.79
, Issue.4
, pp. 301-308
-
-
Kallen, B.A.J.1
Olausson, P.O.2
-
20
-
-
0033943058
-
Congenital Minamata disease: Warnings from Japan's experience
-
Kondo K. 2000. Congenital Minamata disease: warnings from Japan's experience. J Child Neurol 15(7):458-464. (Pubitemid 30460229)
-
(2000)
Journal of Child Neurology
, vol.15
, Issue.7
, pp. 458-464
-
-
Kondo, K.1
-
21
-
-
33645895554
-
The challenge of subgroup analyses: Reporting without distorting
-
Lagakos S. 2006. The challenge of subgroup analyses: reporting without distorting. N Engl J Med 354(16):1667-1669.
-
(2006)
N Engl J Med
, vol.354
, Issue.16
, pp. 1667-1669
-
-
Lagakos, S.1
-
23
-
-
0031809908
-
The use of lithium and management of women with bipolar disorder during pregnancy and lactation
-
Llewellyn A, Stowe Z, Strader J. 1998. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 59(Suppl 6):57-64. (Pubitemid 28313243)
-
(1998)
Journal of Clinical Psychiatry
, vol.59
, Issue.SUPPL. 6
, pp. 57-65
-
-
Llewellyn, A.1
Stowe, Z.N.2
Strader Jr., J.R.3
-
24
-
-
0036711329
-
Teratogenicity of recently introduced medications in human pregnancy
-
Lo WY, Friedman JM. 2002. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol 100(3):465-473.
-
(2002)
Obstet Gynecol
, vol.100
, Issue.3
, pp. 465-473
-
-
Lo, W.Y.1
Friedman, J.M.2
-
25
-
-
34347255039
-
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects
-
DOI 10.1056/NEJMoa067407
-
Louik C, Lin A, Werler M, et al. 2007. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356(26):2675-2683. (Pubitemid 47001035)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.26
, pp. 2675-2683
-
-
Louik, C.1
Lin, A.E.2
Werler, M.M.3
Hernandez-Diaz, S.4
Mitchell, A.A.5
-
26
-
-
0342313474
-
Teratogen update: Thalidomide: a review, with a focus on ocular findings and new potential uses
-
DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y
-
Miller M, Stromland K. 1999. Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses. Teratology 60(5):306-321. (Pubitemid 30265249)
-
(1999)
Teratology
, vol.60
, Issue.5
, pp. 306-321
-
-
Miller, M.T.1
Stromland, K.2
-
27
-
-
0030971463
-
An assessment of boric acid and borax using the IEHR evaluative process for assessing human developmental and reproductive toxicity of agents
-
DOI 10.1016/S0890-6238(96)00204-3
-
Moore J. 1995. An assessment of lithium using the IEHR evaluative process for assessing human developmental and reproductive toxicity of agents. Reprod Toxicol 9(2):175-210. (Pubitemid 27152427)
-
(1997)
Reproductive Toxicology
, vol.11
, Issue.1
, pp. 123-160
-
-
Moore, J.A.1
-
28
-
-
39849106510
-
Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data
-
DOI 10.1002/bdrb.20144
-
Oberlander T, Warburton W, Misri S, et al. 2008. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 83(1):68-76. (Pubitemid 351317794)
-
(2008)
Birth Defects Research Part B - Developmental and Reproductive Toxicology
, vol.83
, Issue.1
, pp. 68-76
-
-
Oberlander, T.F.1
Warburton, W.2
Misri, S.3
Riggs, W.4
Aghajanian, J.5
Hertzman, C.6
-
29
-
-
11844302840
-
Treating individuals 2. Subgroup analysis in randomised controlled trials: Importance, indications, and interpretation
-
Rothwell P. 2005. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet 365(9454):176-186.
-
(2005)
Lancet
, vol.365
, Issue.9454
, pp. 176-186
-
-
Rothwell, P.1
-
30
-
-
14444288534
-
Maternal use of antiepileptic drugs and the risk of major congenital malformations: A joint European prospective study of human teratogenesis associated with maternal epilepsy
-
DOI 10.1111/j.1528-1157.1997.tb01480.x
-
Samren E, van Duijn C, Koch S, et al. 1997. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 38(9):981-990. (Pubitemid 27382935)
-
(1997)
Epilepsia
, vol.38
, Issue.9
, pp. 981-990
-
-
Samren, E.B.1
Van Duijn, C.M.2
Koch, S.3
Hiilesmaa, V.K.4
Klepel, H.5
Bardy, A.H.6
Mannagetta, G.B.7
Deichl, A.W.8
Gaily, E.9
Granstrom, M.L.10
Meinardi, H.11
Grobbee, D.E.12
Hofman, A.13
Janz, D.14
Lindhout, D.15
-
31
-
-
0036128664
-
Update on new developments in the study of human teratogens
-
Shepard TH, Brent RL, Friedman JM, et al. 2002. Update on new developments in the study of human teratogens. Teratology 65(4):153-161.
-
(2002)
Teratology
, vol.65
, Issue.4
, pp. 153-161
-
-
Shepard, T.H.1
Brent, R.L.2
Friedman, J.M.3
-
33
-
-
0026761072
-
Recognition of thalidomide defects
-
Smithells R, Newman C. 1992. Recognition of thalidomide defects. J Med Genet 29:716-723.
-
(1992)
J Med Genet
, vol.29
, pp. 716-723
-
-
Smithells, R.1
Newman, C.2
-
34
-
-
36348939350
-
Statistics in medicine - Reporting of subgroup analyses in clinical trials
-
DOI 10.1056/NEJMsr077003
-
Wang R, Lagakos S, Ware J, et al. 2007. Statistics in medicine: reporting of subgroup analyses in clinical trials. N Engl J Med 357(21):2189-2194. (Pubitemid 350146117)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.21
-
-
Wang, R.1
Lagakos, S.W.2
Ware, J.H.3
Hunter, D.J.4
Drazen, J.M.5
-
35
-
-
58749101057
-
Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy
-
Wichman C, Moore K, Lang T, et al. 2009. Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. Mayo Clin Proc 84(1):23-27.
-
(2009)
Mayo Clin Proc
, vol.84
, Issue.1
, pp. 23-27
-
-
Wichman, C.1
Moore, K.2
Lang, T.3
-
36
-
-
1242314854
-
Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: A nation-wide, population-based register study
-
DOI 10.1080/08035250310021118
-
Wide K, Winbladh B, Kallen B. 2004. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 93(2):174-176. (Pubitemid 38230710)
-
(2004)
Acta Paediatrica, International Journal of Paediatrics
, vol.93
, Issue.2
, pp. 174-176
-
-
Wide, K.1
Winbladh, B.2
Kallen, B.3
-
37
-
-
33750484665
-
Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations
-
DOI 10.1097/01.ede.0000239581.76793.ae, PII 0000164820061100000016
-
Wogelius P, Norgaard M, Gislum M, et al. 2006. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 17(6):701-704. (Pubitemid 44655607)
-
(2006)
Epidemiology
, vol.17
, Issue.6
, pp. 701-704
-
-
Wogelius, P.1
Norgaard, M.2
Gislum, M.3
Pedersen, L.4
Munk, E.5
Mortensen, P.B.6
Lipworth, L.7
Sorensen, H.T.8
|